Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease. (7th May 2021)
- Record Type:
- Journal Article
- Title:
- Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease. (7th May 2021)
- Main Title:
- Combining urine antigen and blood polymerase chain reaction for the diagnosis of disseminated histoplasmosis in hospitalized patients with advanced HIV disease
- Authors:
- Vidal, José E
Werlang, Paula Custodio
Muniz, Bruno M
Rego, Caroline Martins
Barbalho, Renata Elisie
Baptista, André Miranda
Telles, Joao Paulo
da Cruz, Allecineia Bispo
Pereira, Ingrid de Siqueira
Gava, Ricardo
Marcusso, Rosa
Pasqualotto, Alessandro C
Pereira-Chioccola, Vera Lucia - Abstract:
- Abstract: Disseminated histoplasmosis (DH) is endemic in Latin America and the Caribbean where diagnostic tools are restricted. We carried-out a 1-year prospective cohort study at a referral hospital in São Paulo, Brazil. Participants had > or =18 years old, were hospitalized due to any indication and had CD4+ < 200 cells/ µ l. A urine commercial monoclonal Histoplasma galactomannan enzyme-linked immunosorbent assay (IMMY, Norman, OK, USA) and 'in house' Histoplasma blood nested PCR were performed in all cases. Probable/proven DH cases were defined according to international guidelines. Conventional mycological methods were available in routine conditions to investigate suspected DH cases. Treatment of participants followed the institutional routine. One-hundred six participants were included. Median age (interquartile range [IQR]) was 39.5 years (30.0–47.3) and 80 individuals (75.5%) were males. Median (IQR) CD4 cell count was 26.5 (9.4–89.3) cells/mm 3 . DH was diagnosed in 8/106 patients (7.5%). Antigen assay and/or PCR were positive in 4.7% (5/106) of patients. The antigen assay and/or PCR identified 37.5% (3/8) of DH cases, which had not been diagnosed with conventional mycological methods, but had clinical manifestations compatible with HD. In conclusion, the use of Histoplasma urine antigen and Histoplasma blood PCR guided by CD4 status contributed to the diagnosis of DH in hospitalized individuals. These assays were complementary to conventional mycologic methods andAbstract: Disseminated histoplasmosis (DH) is endemic in Latin America and the Caribbean where diagnostic tools are restricted. We carried-out a 1-year prospective cohort study at a referral hospital in São Paulo, Brazil. Participants had > or =18 years old, were hospitalized due to any indication and had CD4+ < 200 cells/ µ l. A urine commercial monoclonal Histoplasma galactomannan enzyme-linked immunosorbent assay (IMMY, Norman, OK, USA) and 'in house' Histoplasma blood nested PCR were performed in all cases. Probable/proven DH cases were defined according to international guidelines. Conventional mycological methods were available in routine conditions to investigate suspected DH cases. Treatment of participants followed the institutional routine. One-hundred six participants were included. Median age (interquartile range [IQR]) was 39.5 years (30.0–47.3) and 80 individuals (75.5%) were males. Median (IQR) CD4 cell count was 26.5 (9.4–89.3) cells/mm 3 . DH was diagnosed in 8/106 patients (7.5%). Antigen assay and/or PCR were positive in 4.7% (5/106) of patients. The antigen assay and/or PCR identified 37.5% (3/8) of DH cases, which had not been diagnosed with conventional mycological methods, but had clinical manifestations compatible with HD. In conclusion, the use of Histoplasma urine antigen and Histoplasma blood PCR guided by CD4 status contributed to the diagnosis of DH in hospitalized individuals. These assays were complementary to conventional mycologic methods and are urgently needed in our setting. Lay Summary: In this prospective cohort study carried-out in a referral center in São Paulo, Brazil, we found a high frequency of AIDS-related disseminated histoplasmosis (8/106, 7.5%). We used urine antigen test and blood PCR assay to improve the diagnosis of this opportunistic disease. … (more)
- Is Part Of:
- Medical mycology. Volume 59:Number 9(2021)
- Journal:
- Medical mycology
- Issue:
- Volume 59:Number 9(2021)
- Issue Display:
- Volume 59, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 59
- Issue:
- 9
- Issue Sort Value:
- 2021-0059-0009-0000
- Page Start:
- 916
- Page End:
- 922
- Publication Date:
- 2021-05-07
- Subjects:
- histoplasmosis -- diagnosis -- urine antigen -- polymerase chain reaction -- Brazil
Medical mycology -- Periodicals
Veterinary mycology -- Periodicals
Mycology -- Periodicals
Mycoses -- Periodicals
Pathogenic fungi -- Periodicals
616.969005 - Journal URLs:
- http://mmy.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/mmy/myab022 ↗
- Languages:
- English
- ISSNs:
- 1369-3786
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5530.168000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25253.xml